Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 527

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Clinical features of hepatocellular carcinoma with extrahepatic metastases

NATSUIZAKA, MITSUTERU, OMURA, TAKUMI, AKAIKE, TORU, KUWATA, YASUAKI, YAMAZAKI, KATSU, SATO, TAKAHIRO, KARINO, YOSHIYASU, TOYOTA, JOUJI, SUGA, TOSHIHIRO, ASAKA, MASAHIRO·2005·Journal of Gastroenterology and Hepatology

Abstract

Background: There are few detailed clinical reports about extrahepatic metastases of hepatocellular carcinoma (HCC). The purpose of the present study was to elucidate the clinical features of extrahepatic metastases of HCC. Methods: The clinical records of 482 patients who had been diagnosed as having HCC during the period from January 1995 to March 2001 were retrospectively reviewed. Extrahepatic metastases had been detected in 65 patients. Clinical features of those 65 patients were analyzed. Results: Patients with extrahepatic metastases had more advanced intrahepatic tumors at the first diagnosis of HCC: 73.8% of the patients with extrahepatic metastases had tumors of intrahepatic tumor stage T3 or T4 according to the TNM classification, while only 28.5% of the patients without extrahepatic metastases had tumors of T3 or T4 (P < 0.001). Vessel invasion was also detected at the first diagnosis of HCC more frequently in the patients with extrahepatic metastasis (P < 0.001). The frequent metastatic sites were lung (53.8%), bone (38.5%), and lymph node (33.8%). Other metastatic sites were the adrenal gland, peritoneum, skin, brain and muscle. The median survival time and 1‐year survival rate were 7 months (range: 1–59 months) and 24.9%, respectively. Patients with Child–Pugh grade B and C (P = 0.0018) and patients with positive serum α‐fetoprotein (P = 0.011) had significantly poor prognosis. Conclusions: Extrahepatic metastases of HCC are not rare. The possibility of extrahepatic metastases and the clinical features of extrahepatic metastases should be considered when examining patients with HCC, particularly those with advanced intrahepatic tumors, to enable precise evaluation of the spread of HCC and determination of the appropriate treatment method. © 2005 Blackwell Publishing Asia Pty Ltd

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1440-1746.2005.03919.x

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 527

Metadata

Authors
NATSUIZAKA, M., OMURA, T., AKAIKE, T., KUWATA, Y., YAMAZAKI, K., SATO, T., KARINO, Y., TOYOTA, J., SUGA, T., & ASAKA, M.
Venue
Journal of Gastroenterology and Hepatology
Publisher
Wiley
Published
2005-10-12
Volume
20
Issue
11
Pages
1781-1787
ISSN
  • 0815-9319 (ISSN-L)
  • 1440-1746
OpenAlex
W2095075235
Cited by
527
References
7
FWCI
7.50
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical features of hepatocellular carcinoma with extrahepatic metastases. https://app.cochat.ai/papers/10.1111/j.1440-1746.2005.03919.x
The paper
NATSUIZAKA, M., OMURA, T., AKAIKE, T., KUWATA, Y., YAMAZAKI, K., SATO, T., KARINO, Y., TOYOTA, J., SUGA, T., & ASAKA, M. (2005). Clinical features of hepatocellular carcinoma with extrahepatic metastases. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/j.1440-1746.2005.03919.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.